N/A
N=85
Long-term Outcomes of Conical Tapered Stems in Cementless Total Hip Arthroplasty Due to Congenital Hip Pathologies
Dysplasia; Hip · Prosthesis Survival
Bottom Line
View on ClinicalTrials.gov: NCT04748458 ↗Enrolled (actual)
85
Serious AEs
0.0%
Results posted
Mar 2022
Primary outcome: Primary: Harris Hip Score — 89.8 points
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- Conical tapered stem (Device)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Istituto Ortopedico Rizzoli
- Primary completion
- Oct 2021
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Harris Hip Score |
89.8 | — |
| PRIMARY Survival Rate |
98.9 | — |
| PRIMARY Radiographic Cup Osseointegration |
98 | — |
| PRIMARY Radiographic Stem Osseointegration |
99 | — |
Summary
A retrospective consecutive population of patients treated with conical tapered stems in cementless total hip arthroplasty for osteoarthritis due to congenital hip pathologies will be selected. The aim of this retrospective study is to evaluate the long-term clinical and radiographic results of this implant and the survival rates in such a specific cohort.
Eligibility Criteria
Inclusion Criteria
- Symptomatic hip osteoarthritis due to congenital hip pathologies
- Consecutive population with a minimum follow-up of 2 years
- Cementless total hip arthroplasty with conical tapered stem
- Pre-operative planning using CT
- Complete clinical and radiographic assessment
Exclusion Criteria
- Other type of hip osteoarthritis
- Other type of implants
- Inadequate pre-operative planning (eg: no CT)
- Incomplete clinical and radiographic assessment
Data sourced from ClinicalTrials.gov (NCT04748458). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.